Tag:
Pacira Pharmaceuticals
Latest Headlines
Latest Headlines
UPDATED: Pacira nets $49M in offering to fuel pain drug Exparel's launch
Pacira Pharmaceuticals ( $PCRX ) expects to raise $49 million from a follow-on offering completed Tuesday to help propel the commercial launch of Exparel, a non-opioid treatment for post-surgical pain...
Pacira's FDA nod marks win for extended-release tech
Pacira Pharmaceuticals ( $PCRX ) has gotten a green light from the FDA to begin sales of its long-acting pain drug Exparel, making the treatment for post-surgical pain the third approved product that
UPDATED: Pacira grabs FDA nod for post-surgery pain drug Exparel
Pacira Pharmaceuticals ( $PCRX ) has gained its first big FDA green light for a drug since wrapping a small IPO in February. U.S. regulators approved the company's long-acting bupivacaine product,
Pacira's long-acting pain drug advancing
En route to a potential FDA approval next month, Pacira Pharmaceuticals ( $PCRX ) reports data from previous trials of its lead drug Exparel for postsurgical pain. In patients who had surgery to
Pacira slashes IPO price while AcelRx braves a chilly market
Looking to raise cash to bankroll the expected release of a late-stage drug designed to treat post-surgery pain, Pacira Pharmaceuticals is closing in on an IPO this week. But in a fresh sign of just
Pacira licenses DepoFoam to Novo Nordisk, plans IPO
Parsippany, NJ-based Pacira Pharmaceuticals, which makes controlled-release injectable products, has licensed its DepoFoam drug delivery technology to Danish drugmaker Novo Nordisk. The deal could be
Pacira adds $55M in venture funds
Hey, it's not all bad news out there. Despite the drumbeat of reports on the fallout from the credit crisis, two more biotechs report lining up new rounds. A new regulatory filing reveals that Pacira
